SEC Comment Letter for Anixa Biosciences Inc (ANIX) (CIK 0000715446) (ANIX) — Jul 27, 2010

Anixa Biosciences Inc (ANIX) (CIK 0000715446)
Date: July 27, 2010 · CIK: 0000715446 · Accession: 0000000000-10-042497

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-11254

Date

July 27, 2010

Author

Mark P. Shuman

Form

UPLOAD

Company

Anixa Biosciences Inc (ANIX) (CIK 0000715446)

Letter

July 27, 2010

Denis A. Krusos Chief Executive Officer CopyTele, Inc. 900 Walt Whitman Road Melville, New York 11747 Re: CopyTele, Inc. Form 10-K/A for Fiscal Year Ended October 31, 2009 Filed June 29, 2010 File No. 000-11254 Dear Mr. Krusos: We have completed our review of your fili ng and do not have any further comments at this time. Sincerely,

Mark P. Shuman Branch Chief – Legal

cc: Via facsimile to: (212) 208-4451

Michael D. Schwamm Duane Morris LLP

Show Raw Text

July 27, 2010

Denis A. Krusos Chief Executive Officer CopyTele, Inc. 900 Walt Whitman Road Melville, New York 11747
Re: CopyTele, Inc.
Form 10-K/A for Fiscal Year Ended October 31, 2009 Filed June 29, 2010 File No. 000-11254
 Dear Mr. Krusos:
We have completed our review of your fili ng and do not have any further comments at
this time.
Sincerely,

Mark P. Shuman Branch Chief – Legal

cc:   Via facsimile to: (212) 208-4451

 Michael D. Schwamm
 Duane Morris LLP

SecProbe.io